ArticleGMS hygiene and infection control2026
Active surveillance cultures for multidrug-resistant Gram-negative organisms in the intensive care unit: is it necessary to conduct them weekly?
Article in GMS hygiene and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Multidrug-resistant Gram-negative bacteria (MDR-GNB) pose a major threat to public health due to the limited treatment options and their frequent association with healthcare-associated infections. Active surveillance culture (ASC), a component of infection prevention strategies, remains controversial. This study evaluated the effectiveness of ASC performed weekly versus only upon ICU admission and discharge for detecting MDR-GNB. Materials and methods: In a prospective study, two monitoring strategies were compared over a period of 18 months in six intensive care units. Phase 1 involved conducting ASC weekly, while Phase 2 entailed conducting ASC exclusively at the time of ICU admission and discharge. Results: A total of 233 MDR-GNB infections were documented: 130 (11.38/1,000 patient-days) in Phase 1 and 103 (8.47/1,000 patient-days) in Phase 2. This reflects a statistically significant decrease in infection rates in Phase 2 (IRR: 1.34; 95% CI: 1.04-1.74). No significant differences were observed in species-specific infection rates between the two phases. Conclusions: Reducing ASC frequency from weekly to only ICU admission and discharge did not increase MDR-GNB infection rates. The implementation of comprehensive infection prevention and control measures proved sufficient for the management of bacterial infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.